Table 2 Key clinical features of women with ovarian malignant tumors, ovarian benign tumors and healthy women (controls)
Characteristics | Malignant | Benign | Controls | p-value | p-value | p-value |
|---|---|---|---|---|---|---|
(n = 60) | (n = 116) | (n = 150) | (Malignant vs. benign) | (Malignant vs. controls) | (Benign vs. controls) | |
Age | ||||||
Years, mean (SD)* | 50.8 (20.5) | 47.9 (16.6) | 44.4 (12.6) | 0.45 | 0.02 | 0.18 |
Menopausal status Ŧ | ||||||
Premenopausal | 23 (38.3) | 68 (57.8) | 79 (52.6) | |||
Postmenopausal | 38 (61.7) | 49 (42.2) | 71 (48.4) | <0.01 | 0.05 | 0.37 |
Body mass index (BMI) – kg/m 2 | ||||||
Mean (+/− SD)* | 28.3 (+/−6.3) | 28.0 (+/−5.5) | 27.2 (+/−5.0) | 0.42 | 0.37 | 0.40 |
Histology | ||||||
Epithelial | 47 (78.3) | 40 (34.5) | - | - | - | - |
Invasive | 37 (78.7) | |||||
Borderline | 10 (21.3) | |||||
Germ line | 6 (10.0) | 28 (24.1) | - | - | - | - |
Sex cord and Stromal | 7 (12.7) | 20 (17.3) | - | - | - | - |
Non-neoplasic | - | 28 (24.1) | - | - | - | - |
Stage | ||||||
I | 32 (53.3) | |||||
II | 5 (8.3) | |||||
III | 22 (36.7) | |||||
IV | 1 (1.7) | |||||